Subcutaneous Mass Evaluation and Management
Most Likely Diagnosis
A small, firm subcutaneous mass present for years with very slow growth is most likely a benign lipoma, which accounts for the overwhelming majority (96%) of superficial soft tissue masses. 1, 2
Initial Diagnostic Approach
Step 1: Plain Radiographs First
- Obtain plain radiographs as the initial imaging study, which can identify intrinsic fat in approximately 11% of soft tissue masses and detect calcification or bone involvement 2, 3
- Radiographs identify positive findings in 62% of cases and are essential before proceeding to other modalities 3
Step 2: Ultrasound for Superficial Masses
- Ultrasound is the first-line imaging modality for suspected subcutaneous lipomas, with sensitivity of 86.87-94.1% and specificity of 95.95-99.7% 2, 3
- Characteristic ultrasound features of benign lipomas include:
Critical Red Flags Requiring Advanced Imaging
You must obtain MRI with and without contrast if any of the following features are present: 1, 2, 3
- Size larger than 5 cm
- Deep location (subfascial)
- Rapid growth or recent change in growth rate
- Pain or tenderness
- Firm consistency with irregular margins
- Atypical ultrasound features (thick septations, nodularity, or soft tissue components)
When to Suspect Atypical Lipomatous Tumor (ALT)
Any lipomatous mass that is increasing in size, deep-seated, or located in the lower limb raises concern for atypical lipomatous tumor (well-differentiated liposarcoma), which requires different surgical management due to its propensity for local recurrence 1, 2
MRI Characteristics Suggesting ALT vs Benign Lipoma
- MRI can distinguish benign lipomas from ALT in up to 69% of cases based on: 2
- Nodularity within the mass
- Thick septations (>2mm)
- Soft tissue stranding
- Relative size and deep location
- Masses that lack isointense signal to subcutaneous fat on MRI may represent sarcoma and require biopsy 5
Tissue Diagnosis Algorithm
When Biopsy is Required
Obtain core needle biopsy under image guidance if: 2, 3
- MRI shows concerning features (nodularity, thick septations, stranding)
- Diagnostic uncertainty persists after imaging
- Any mass with firm consistency, irregular margins, size >5 cm, or rapid growth
Biopsy Technique
- Multiple core samples should be obtained to maximize diagnostic yield 3
- Request MDM-2 amplification analysis by fluorescence in-situ hybridization, which is the defining diagnostic test to differentiate lipoma from ALT 2, 3
- For small lesions (<2 cm or <5 cm depending on source), excisional biopsy may be more practical 2, 3
- Plan the biopsy tract for potential excision if malignancy is found 4
Management Based on Diagnosis
For Typical Benign Lipoma
Observation is appropriate for small (<5 cm), asymptomatic, superficial lipomas with typical ultrasound features, with clinical follow-up rather than imaging follow-up being sufficient 2
Indications for Surgical Excision
Complete en bloc surgical excision is indicated when the lipoma is: 2
- Symptomatic
- Rapidly growing
- Large (>5 cm)
- Showing atypical features on imaging
For Confirmed ALT
- If MDM-2 positive (confirming ALT), refer to sarcoma specialist for marginal en bloc resection 2
- ALT requires en bloc resection even if margins are R1, whereas simple lipoma excision requires different margins 2
Critical Pitfalls to Avoid
Physical examination alone correctly identifies only about 85% of soft tissue tumors, making imaging mandatory 3
Ultrasound accuracy drops precipitously for deep lipomas compared to superficial ones—all deep-seated lipomas or those in the lower limb should raise concern for atypical lipomatous tumors 1, 2
Avascularity does not guarantee benignity, as some malignant lesions can be relatively avascular, though this is uncommon 4
Any retroperitoneal or intra-abdominal mass with imaging suggestive of soft tissue sarcoma should be referred to a specialist sarcoma multidisciplinary team before surgical treatment 1, 2
Do not assume all slow-growing masses are benign—giant lipomas (>10 cm) represent only 1% of lipomas but can undergo malignant transformation, calcification, or other changes, particularly in subcutaneous tissues of the thigh, buttock, or retroperitoneum 6, 7